Aroa Biosurgery Limited
Research Aroa Biosurgery Limited (ARX.AX) on Bullrun: market cap AUD 178.65M, P/E 51.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerARX.AX
- ExchangeAU
- CountryNew Zealand
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 178.65M
- P/E51.0
- Financial periodFY2026
- RevenueAUD 86.60M
- Revenue growth12.5%
- Net incomeAUD 3.90M
- Free cash flowAUD 5.68M
- Gross margin85.5%
Valuation Snapshot
latest market cap is AUD 178.65M; P/E is 51.0.
Peer valuation comparison
Latest P/E is 51x versus a Healthcare sector median of 24.73x (106.2% above).
Latest P/E is 51x versus a New Zealand median of 27.68x (84.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 86.60M | AUD 3.90M | AUD 5.68M | 85.5% | 0.01 | AUD 17.56M | AUD 5.32M | AUD 82.84M |
| FY2025 | AUD 76.97M | -AUD 3.47M | -AUD 5.69M | 85.7% | -0.01 | AUD 7.26M | AUD 5.83M | AUD 84.59M |
| FY2024 | AUD 63.36M | -AUD 9.75M | -AUD 13.17M | 85.4% | -0.03 | AUD 10.57M | AUD 6.82M | AUD 87.09M |
| FY2023 | AUD 59.31M | -AUD 370.68K | -AUD 10.66M | 84.4% | 0 | AUD 8.93M | AUD 6.65M | AUD 95.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | AUD 178.65M | 51.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Aroa Biosurgery Limited
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aroa Biosurgery Limited's market cap?
Aroa Biosurgery Limited's market capitalization is AUD 178.65M.
What is Aroa Biosurgery Limited's P/E ratio?
Aroa Biosurgery Limited's price-to-earnings (P/E) ratio is 51.0.
What does Aroa Biosurgery Limited do?
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.